New analytic tools: backward compatibility enhances scanning laser tomography

Article

Stability of technology is important when dealing with patients who have a progressive disease, said Balwantray Chauhan, PhD, professor and director of research, Department of Ophthalmology, Dalhousie University, Halifax, Nova Scotia.

Stability of technology is important when dealing with patients who have a progressive disease, said Balwantray Chauhan, PhD, professor and director of research, Department of Ophthalmology, Dalhousie University, Halifax, Nova Scotia.

When technology is continually upgraded, clinicians sometimes find that they are no longer able to view images taken years ago, which is clearly a disadvantage in dealing with slowly progressing conditions such as glaucoma, Dr. Chauhan said. Confocal scanning laser tomography (which was developed 25 years ago) lends itself to backward compatibility, however.

As a glaucoma specialist, Dr. Chauhan is interested in variability over a short period; when this is known, one can set limits that define change and establish criteria for change. Several techniques have been developed to help clinicians measure change with confocal scanning laser tomography.

Both statistic image mapping (SIM) and topographic change analysis (TCA) are effective techniques for detecting topographic change in series of images, Dr. Chauhan said.

"With both SIM and TCA, you can apply images that were captured in the early 1990s, for example, and start to reveal things that weren't really obvious at the time because of the backward compatibility," Dr. Chauhan said.

In evaluating images, it is also important to be able to correct for spatial correlation, Dr. Chauhan concluded. Doing so considerably decreases the amount of noise that may affect the accuracy of the interpretation.

Newsletter

Join ophthalmologists across Europe—sign up for exclusive updates and innovations in surgical techniques and clinical care.

Recent Videos
Alfredo Sadun, MD, PhD, chief of Ophthalmology at the Doheny Eye Institute, University of California Los Angeles, shared exciting new research with the Eye Care Network during the Association for Research in Vision and Ophthalmology (ARVO) meeting on the subject of Leber hereditary optic neuropathy (LHON).
At this year's Association for Research in Vision and Ophthalmology (ARVO) meeting in Salt Lake City, Utah, Nitish Mehta, MD, shared highlights from his research documenting real-world results of aflibercept 8 mg for patients with diabetic macular oedema.
ARVO 2025: Anat Loewenstein, MD, shares data from herself and her colleagues on meeting needs of patients with diabetic retinopathy
At the American Society of Cataract and Refractive Surgeons annual meeting, Sheng Lim, MD, FRCOphth discusses the benefit of endoscopic cyclophotocoagulation for patients with primary open angle glaucoma and cataracts in the CONCEPT study
A photo of Seville, Spain, with the Congress on Controversies in Ophthalmology logo superimposed on it. Image credit: ©francovolpato – stock.adobe.com; logo courtesy COPHy
Anat Loewenstein, MD, Professor and Director, Department of Ophthalmology, Tel Aviv Medical Center, discusses the Congress on Controversies in Ophthalmology (COPHy)
(Image credit: Ophthalmology Times Europe) AGS 2025: Clemens Strohmaier, PhD, on improving aqueous humour outflow following excimer laser trabeculostomy
3 experts are featured in this series.
Anat Loewenstein, MD, speaks about the 22nd Annual Angiogenesis, Exudation, and Degeneration Meeting in February 2025 and shares her global forecast for AI-driven home OCT
3 experts are featured in this series.
Related Content
© 2025 MJH Life Sciences

All rights reserved.